These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19557545)

  • 1. Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process.
    Hůlková H; Ledvinová J; Poupetová H; Kohout A; Malinová V; Elleder M
    J Inherit Metab Dis; 2009 Aug; 32(4):551-9. PubMed ID: 19557545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement therapy reduces Gaucher cell burden but may accelerate osteopenia in patients with type I disease - a histological study.
    Rudzki Z; Okoń K; Machaczka M; Rucińska M; Papla B; Skotnicki AB
    Eur J Haematol; 2003 May; 70(5):273-81. PubMed ID: 12694162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological characterisation of visceral changes in a patient with type 2 Gaucher disease treated with enzyme replacement therapy.
    Tezuka Y; Fukuda M; Watanabe S; Nakano T; Okamoto K; Kuzume K; Yano Y; Eguchi M; Ishimae M; Ishii E; Miyazaki T
    Blood Cells Mol Dis; 2018 Feb; 68():194-199. PubMed ID: 27866810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease.
    Wenstrup RJ; Kacena KA; Kaplan P; Pastores GM; Prakash-Cheng A; Zimran A; Hangartner TN
    J Bone Miner Res; 2007 Jan; 22(1):119-26. PubMed ID: 17032149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease.
    Elstein D; Mehta A; Hughes DA; Giraldo P; Charrow J; Smith L; Shankar SP; Hangartner TN; Kunes Y; Wang N; Crombez E; Zimran A
    Am J Hematol; 2015 Jul; 90(7):592-7. PubMed ID: 25776130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase.
    Pastores GM; Petakov M; Giraldo P; Rosenbaum H; Szer J; Deegan PB; Amato DJ; Mengel E; Tan ES; Chertkoff R; Brill-Almon E; Zimran A
    Blood Cells Mol Dis; 2014 Dec; 53(4):253-60. PubMed ID: 24950666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J; Szücs FZ; Benkö K; Maródi L
    Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Velaglucerase alfa for the management of type 1 Gaucher disease.
    Morris JL
    Clin Ther; 2012 Feb; 34(2):259-71. PubMed ID: 22264444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Bowel Mucosal Involvement and Mesenteric Mass Formation in a Young Female with Type 3 Gaucher Disease. A Case Report.
    Emanuel AJ; Holman N; Presnell SE; Welsh CT; Pai S; Sun S
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):459-463. PubMed ID: 30574629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.
    El-Beshlawy A; Tylki-Szymanska A; Vellodi A; Belmatoug N; Grabowski GA; Kolodny EH; Batista JL; Cox GF; Mistry PK
    Mol Genet Metab; 2017; 120(1-2):47-56. PubMed ID: 28040394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment.
    Weinreb NJ; Camelo JS; Charrow J; McClain MR; Mistry P; Belmatoug N;
    Mol Genet Metab; 2021 Feb; 132(2):100-111. PubMed ID: 33485799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
    Pastores GM
    Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat.
    Mikosch P; Reed M; Baker R; Holloway B; Berger L; Mehta AB; Hughes DA
    Calcif Tissue Int; 2008 Jul; 83(1):43-54. PubMed ID: 18553043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy with imiglucerase in Taiwanese patients with type I Gaucher disease.
    Hsu CC; Chien YH; Lai MY; Hwu WL
    J Formos Med Assoc; 2002 Sep; 101(9):627-31. PubMed ID: 12645190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement therapy with imiglucerase in a Taiwanese child with type 1 Gaucher disease.
    Lin HY; Lin SP; Chuang CK; Wraith JE
    J Chin Med Assoc; 2006 May; 69(5):228-32. PubMed ID: 16835986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant macrophage targeted enzyme replacement therapy for Gaucher disease in India.
    Nagral A; Mewawalla P; Jagadeesh S; Kabra M; Phadke SR; Verma IC; Puri RD; Gupta N; Kishnani PS; Mistry PK
    Indian Pediatr; 2011 Oct; 48(10):779-84. PubMed ID: 22080680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant glucocerebrosidase (imiglucerase) as a therapy for Gaucher disease.
    Pastores GM
    BioDrugs; 2010 Feb; 24(1):41-7. PubMed ID: 20055531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cessation of enzyme replacement therapy in Gaucher disease.
    Grinzaid KA; Geller E; Hanna SL; Elsas LJ
    Genet Med; 2002; 4(6):427-33. PubMed ID: 12509713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiglucerase treatment in Gaucher's disease.
    Shah U; Nadeem N; Husen Y; Fadoo Z
    J Ayub Med Coll Abbottabad; 2007; 19(2):56-9. PubMed ID: 18183722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.